ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,433.18
      0.11%
      US Tech 100
      18,420.00
      -0.62%
      Dow Jones
      39,995.20
      0.35%
      Brent Oil
      80.06
      -0.84%
      Bitcoin
      64,706.17
      -1.02%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE

      6. Stevanato Group SpA (STVN) Quote

      Stevanato Group SpA

      Stevanato Group SpA (STVN)

      NYSE
      19.90
      -1.85
      ( -8.51% )
      Updated: 10:31:34
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      19.90
      Bid
      -
      Ask
      -
      Volume
      1,052,024
      18.985 Day's Range 21.145
      16.56 52 Week Range 36.30
      Market Cap
      5.881B
      Previous Close
      21.75
      Open
      21.00
      Last Trade
      100
      @
      19.9
      Last Trade Time
      10:31:34
      Financial Volume
      $ 21,204,048
      VWAP
      20.1555
      Average Volume (3m)
      727,105
      Shares Outstanding
      295,540,036
      Dividend Yield
      -
      PE Ratio
      41.88
      Earnings Per Share (EPS)
      0.49
      Revenue
      1.1B
      Net Profit
      145.63M

      About Stevanato Group SpA

      Italy-based Stevanato Group is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire ... Italy-based Stevanato Group is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. Stevanato's revenue is geographically diversified, with 60% of sales from Europe, the Middle East and Africa (EMEA), 27% in North America, 10% in Asia-Pacific (APAC), and 3% in South America. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.stevanatogroup.com/en
      Headquarters
      Pioltello, Lombardy, Ita
      Founded
      1970
      Stevanato Group SpA is listed in the Pharmaceutical Preparations sector of the New York Stock Exchange with ticker STVN. The last closing price for Stevanato was $21.75. Over the last year, Stevanato shares have traded in a share price range of $ 16.56 to $ 36.30.

      Stevanato currently has 295,540,036 shares outstanding. The market capitalization of Stevanato is $6.43 billion. Stevanato has a price to earnings ratio (PE ratio) of 41.88.

      STVN Latest News

      More News

      FeaturedSouthern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project

      3 hours ago

      Stevanato Group to Report Second Quarter 2024 Financial Results on August 6, 2024

      Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries...

      4 hours ago
      Business Wire

      Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

      June 11 2024
      Edgar (US Regulatory)

      Form SD - Specialized disclosure report

      May 31 2024
      Edgar (US Regulatory)

      Stevanato Group Unveils New Plant in Cisterna di Latina for the Production of Pre-Sterilized EZ-fill® Syringes and Cartridges

      Cisterna’s site is the first to implement premium solutions outside the Group’s headquarters in Piombino Dese to meet the growing demand for biopharmaceuticals, such as GLP-1s in Europe...

      May 30 2024
      Business Wire

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      May 28 2024
      Edgar (US Regulatory)

      Stevanato Group Appoints Franco Stevanato Chief Executive Officer, Succeeding Franco Moro

      Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries...

      May 28 2024
      Business Wire

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      May 24 2024
      Edgar (US Regulatory)

      Stevanato Group Announces Results of Annual General Meeting

      -All Resolutions Proposed to Shareholders Passed- Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical...

      May 24 2024
      Business Wire

      Stevanato Group to Present at Upcoming Investor Conferences

      Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries...

      May 23 2024
      Business Wire
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-1.85-8.5057471264421.7522.4518.98554174321.61192425CS
      42.615.028901734117.322.8316.8566801420.48992762CS
      12-8.73-30.492490394728.6328.8816.5672710520.32464003CS
      26-10.37-34.258341592330.2734.7316.5653336624.18529073CS
      52-12.76-39.069197795532.6636.316.5642359026.1751784CS
      156-0.74-3.5852713178320.6436.313.35537567922.88002726CS
      2603.2519.519519519516.6536.313.35538759322.75632563CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      POAIPredictive Oncology Inc
      $ 2.5094
      (134.52%)
      		115.59M
      PBMPsyence Biomedical Ltd
      $ 0.73
      (86.51%)
      		57.25M
      SLRXSalarius Pharmaceuticals Inc
      $ 3.275
      (53.04%)
      		12.92M
      VKTXViking Therapeutics Inc
      $ 66.02
      (30.97%)
      		7.23M
      GSHDGoosehead Insurance Inc
      $ 84.79
      (29.06%)
      		322.28k
      TWOU2U Inc
      $ 1.59
      (-61.41%)
      		2.05M
      EZFLEzFill Holdings Inc
      $ 3.86
      (-37.99%)
      		50.01k
      KDLYKindly MD Inc
      $ 2.07
      (-35.71%)
      		427.26k
      MXLMaxLinear Inc
      $ 16.0199
      (-28.13%)
      		1.85M
      GLYCGlycoMimetics Inc
      $ 0.2279
      (-26.55%)
      		3.86M
      NVDANVIDIA Corporation
      $ 110.5146
      (-3.27%)
      		153.92M
      POAIPredictive Oncology Inc
      $ 2.5094
      (134.52%)
      		115.59M
      SLNASelina Hospitality PLC
      $ 0.0432
      (-5.47%)
      		110.58M
      SQQQProShares UltraPro Short QQQ
      $ 9.29
      (2.54%)
      		78.76M
      STSSSharps Technology Inc
      $ 0.268
      (12.94%)
      		57.48M

      STVN Discussion

      View Posts
      weedtrader420 weedtrader420 3 years ago
      STVN $50 TARGET PRICE WOOHOOOOOO
      👍️0
      Glider549 Glider549 3 years ago
      Picks and shovels!
      Love it!
      👍️0
      weedtrader420 weedtrader420 3 years ago
      Owns 80% of the vaccine Bottling business They make almost every vaccine bottle
      👍️0

      Your Recent History

      NYSE
      STVN
      Stevanato
      Delayed Upgrade Clock